NCT06789016View on ClinicalTrials.gov

Dexmedetomidine for ESPB in Pain Management After Pediatric Idiopathic Scoliosis Surgery

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

May 30, 2025

Study Completion Date

July 30, 2025

Conditions
Scoliosis IdiopathicScoliosisScoliosis; Adolescence
Interventions
DRUG

Dexmedetomidine

administration of 0.5ml/kg of 0.2% ropivacaine with 0.1ug/kg Dexmedetomidine for the erector spine plane block

DRUG

0.9%NaCl

administration of 0.5ml/kg of 0,2% ropivacaine + 0.01ml/kg 0.9% sodium chloride for the erector spine plane block

Trial Locations (1)

61-545

Department of Spine Diseases and Pediatric Orthopedics, University of Medical Sciences, Poznań, Poland, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER